Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Predictive Oncology Inc. | f10k_032720p.htm |
| EX-31.2 - EXHIBIT 31.2 - Predictive Oncology Inc. | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - Predictive Oncology Inc. | exh_311.htm |
| EX-23.1 - EXHIBIT 23.1 - Predictive Oncology Inc. | exh_231.htm |
| EX-4.29 - EXHIBIT 4.29 - Predictive Oncology Inc. | exh_429.htm |
| EX-3.14 - EXHIBIT 3.14 - Predictive Oncology Inc. | exh_314.htm |
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSWUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Form 10-K of Predictive Oncology Inc. (the “Company”) for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Carl Schwartz, Chief Executive Officer, and I, Bob Myers, Chief Financial Officer, of the Company, certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350, that to our knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: March 31, 2020
/s/ Carl Schwartz
Carl Schwartz
Chief Executive Officer
(Principal Executive Officer)
/s/ Bob Myers
Bob Myers
Chief Financial Officer
(Principal Financial Officer)